265 related articles for article (PubMed ID: 15760378)
21. Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.
Kim M; Taylor J; Sidney J; Mikloska Z; Bodsworth N; Lagios K; Dunckley H; Byth-Wilson K; Denis M; Finlayson R; Khanna R; Sette A; Cunningham AL
J Immunol; 2008 Nov; 181(9):6604-15. PubMed ID: 18941251
[TBL] [Abstract][Full Text] [Related]
22. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
23. Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.
Xia J; Veselenak RL; Gorder SR; Bourne N; Milligan GN
PLoS One; 2014; 9(12):e114652. PubMed ID: 25485971
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.
Mikloska Z; Cunningham AL
J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620
[TBL] [Abstract][Full Text] [Related]
25. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
26. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.
Akdis M; Simon HU; Weigl L; Kreyden O; Blaser K; Akdis CA
J Immunol; 1999 Jul; 163(1):466-75. PubMed ID: 10384150
[TBL] [Abstract][Full Text] [Related]
27. Development of a therapeutic vaccine for HSV-2.
Hosken NA
Vaccine; 2005 Mar; 23(17-18):2395-8. PubMed ID: 15755634
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
Braun RP; Payne LG; Dong L
Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
[TBL] [Abstract][Full Text] [Related]
29. Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor.
Koelle DM; Liu Z; McClurkan CL; Cevallos RC; Vieira J; Hosken NA; Meseda CA; Snow DC; Wald A; Corey L
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12899-904. PubMed ID: 14566059
[TBL] [Abstract][Full Text] [Related]
30. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet.
Svensson A; Nordström I; Sun JB; Eriksson K
J Immunol; 2005 May; 174(10):6266-73. PubMed ID: 15879125
[TBL] [Abstract][Full Text] [Related]
31. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
[TBL] [Abstract][Full Text] [Related]
32. Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.
Samandary S; Kridane-Miledi H; Sandoval JS; Choudhury Z; Langa-Vives F; Spencer D; Chentoufi AA; Lemonnier FA; BenMohamed L
Hum Immunol; 2014 Aug; 75(8):715-29. PubMed ID: 24798939
[TBL] [Abstract][Full Text] [Related]
33. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
Sin JI; Kim JJ; Zhang D; Weiner DB
Hum Gene Ther; 2001 Jun; 12(9):1091-102. PubMed ID: 11399230
[TBL] [Abstract][Full Text] [Related]
34. Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms.
Dobbs ME; Strasser JE; Chu CF; Chalk C; Milligan GN
J Virol; 2005 Dec; 79(23):14546-54. PubMed ID: 16282454
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T-cells suppress antigen-specific and allogeneic CD4+ T-cell responses to herpes simplex virus type 2-infected human dendritic cells.
Nordström I; Nurkkala M; Collins LV; Eriksson K
Viral Immunol; 2005; 18(4):616-26. PubMed ID: 16359228
[TBL] [Abstract][Full Text] [Related]
36. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
37. Long term persistence of herpes simplex virus-specific CD8+ CTL in persons with frequently recurring genital herpes.
Posavad CM; Huang ML; Barcy S; Koelle DM; Corey L
J Immunol; 2000 Jul; 165(2):1146-52. PubMed ID: 10878394
[TBL] [Abstract][Full Text] [Related]
38. Role of Interleukin 32 in Human Immunodeficiency Virus Reactivation and Its Link to Human Immunodeficiency Virus-Herpes Simplex Virus Coinfection.
Mesquita PMM; Preston-Hurlburt P; Keller MJ; Vudattu N; Espinoza L; Altrich M; Anastos K; Herold KC; Herold BC
J Infect Dis; 2017 Feb; 215(4):614-622. PubMed ID: 28007920
[TBL] [Abstract][Full Text] [Related]
39. Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection.
Johnson AJ; Nelson MH; Bird MD; Chu CF; Milligan GN
J Reprod Immunol; 2010 Jan; 84(1):8-15. PubMed ID: 19942296
[TBL] [Abstract][Full Text] [Related]
40. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells.
Picker LJ; Treer JR; Ferguson-Darnell B; Collins PA; Bergstresser PR; Terstappen LW
J Immunol; 1993 Feb; 150(3):1122-36. PubMed ID: 7678617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]